Hansen Ree, A. (2022) “Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study”, Acta Oncologica, 61(8), pp. 955–962. doi: 10.1080/0284186X.2022.2098053.